Risk Profile Improvements
- Material Weakness (improved) — Company remediated one of three prior material weaknesses (GAAP application controls that caused restatements) but still reports ineffective controls due to lack of documentation and segregation of duties.
SSII doubles revenue to $42.5M, files FDA 510(k), raises $18.6M; installed base triples to 168 systems
Filed March 10, 2026 · Period ending December 31, 2025 · Compared to 10-K Apr 15, 2025 · ~2 min read
5 material changes detected in this filing.
Create a free account to read the full summary — it takes 30 seconds.
Partner
Trade SSII commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Generated by AI · Jun 5, 2026 5:40 AM